Human immunodeficiency virus (HIV)-associated infection involves the entry of virus-bearing monocytes into the brain, followed by microglial activation, neuroinflammation, and upregulated arachidonic acid (AA) metabolism. The HIV-1 transgenic (Tg) rat, a noninfectious HIV-1 model, shows neurologic and behavioral abnormalities after 5 months of age. We hypothesized that brain AA metabolism would be elevated in older HIV-1 Tg rats in vivo. Arachidonic acid incorporation from the plasma into the brain of unanesthetized 7-to-9-month-old rats was imaged using quantitative autoradiography, after [1-
Introduction
Clinical manifestations of human immunodeficiency virus (HIV-1)/(acquired immunodeficiency syndrome) include depression, motor abnormalities, peripheral neuropathies, mild HIV cognitive impairment, and HIV-1-associated dementia (HAD) (Anthony and Bell, 2008; May et al, 2007) . The central nervous system changes are believed to follow entry into the brain of circulating monocytes containing the HIV-1 virus, followed by proliferation and shedding of the virus to induce microglial activation and neuroinflammation (D'Aversa et al, 2005) . The brains of presymptomatic patients may show leptomeningitis and perivascular lymphocytic cuffing, with infiltrates of CD8-and CD20-positive B lymphocytes, subtle gliosis, and microglia activation, but more extensive changes are found in patients with HAD (Anthony and Bell, 2008) . Brain levels of proinflammatory cytokines, tumor necrosis factor-a, and interleukin-1b, are elevated in HAD patients . Increased cerebrospinal fluid concentrations of arachidonic acid (AA, 20:4n-6)-derived eicosanoids prostaglandin (PG)E 2 , PGF 2a , and thromboxane (TX)B 2 indicate upregulation of the brain AA cascade (Bosetti, 2007) . Similar upregulation is reported in animal models of neuroinflammation and excitotoxicity (Lee et al, 2004 (Lee et al, , 2008 Rao et al, 2007; Rosenberger et al, 2004) .
A noninfectious HIV-1 transgenic (Tg) rat has been developed. This rat has a functional deletion of Gag and Pol but constitutively expresses other HIV-1-related proteins (such as Tat, gp120, Nef, and Rev), and shows immunologic abnormalities similar to abnormalities with human infection (Reid et al, 2001 ). After 5 months of age, the rat develops behavioral deficits and its brain shows activated microglia characteristic of neuroinflammation (Lashomb et al, 2009; Reid et al, 2001) .
On the basis of the evidence of neuroinflammation and upregulated brain AA metabolism in HAD patients Wesselingh et al, 1994) , we hypothesized a similar upregulation in older HIV-1 Tg rats. To test this, we used our in vivo fatty acid technique to quantitatively image AA incorporation into the brain of unanesthetized 7-to-9-month-old HIV-1 Tg rats and of age-matched controls (Robinson et al, 1992) . Regional incorporation coefficients k* and incorporation rates J in of unesterified circulating AA, which represent regional rates of AA metabolic loss from the brain (DeMar et al, 2006) , were determined. We also measured brain activities of phospholipase A 2 (PLA 2 ) enzymes that release AA and/or docosahexaenoic acid (DHA, 22:6n-3) from the stereospecifically numbered (sn)-2 position of membrane phospholipid (Six and Dennis, 2000) , and brain concentrations of AA-derived metabolites (eicosanoids), PGE 2 , leukotriene (LT)B 4 , and TXB 2 (Bosetti, 2007) . Cortical expression and cellular localization of cytosolic (c)PLA 2 -IV, secretory (s)PLA 2 -IIA, and cyclooxygenase (COX)-2 were determined by immunostaining.
Materials and methods

Animals
Male HIV-1 Tg rats (7-to-9-month old) derived from Fischer 344/NHsd Sprague-Dawley and age-matched parental control inbred Fischer 344/Hsd non-Tg rats (Harlan, Indianapolis, IN, USA) were housed under a light-dark cycle with ad libitum access to water and Teklad global 18% protein diet, 2018S (sterilized) for controls and 2918 (irradiated) for HIV-1 Tg rats (Harlan). The 2018 diet contained soybean oil but not fishmeal, and had 5% crude fat by weight. Gas-liquid chromatography showed that fatty acid concentrations were (as % total fatty acids): 16.7% saturated, 21.8% monounsaturated, 54.8% linoleic, 6.2% a-linolenic, 0.03% AA, 0.02% eicosapentaenoic, and 0.06% DHA. Experiments were conducted following the 'Guide for the Care and Use of Laboratory Animals' (National Institutes of Health Publication No. 86-23), and were approved by the Animal Care and Use Committee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Surgical Procedures and Tracer Infusion
A rat was anesthetized with 2% to 3% halothane/O 2 and catheters were inserted into the right femoral artery and vein as reported previously (Basselin et al, 2007) . The rat was allowed to recover from anesthesia for 3 hours in a sound-dampened, temperature-controlled chamber with its hindquarters loosely wrapped and taped to a wooden block. Arterial blood pressure and heart rate were recorded (CyQ 103/302; Cybersense, Nicholasville, KY, USA).
[1-14 C]AA (170 mCi/kg; 49.2 mCi/mmol, > 99% pure, Moravek Biochemicals, Brea, CA, USA) in 5 mmol/L HEPES buffer (pH 7.4), containing 50 mg/mL fatty acid-free bovine serum albumin, was infused through the femoral vein (5 minutes, 400 mL/min) using an infusion pump (Harvard Apparatus Model 22, Harvard Apparatus, Natick, MA, USA) (Basselin et al, 2007) . Fifteen minutes later, the rat was killed with Nembutal (80 mg/kg, intravenous) and the brain was removed, frozen in 2-methylbutane maintained at À401C with dry ice, and stored at À801C.
Chemical Analysis
Overall, 13 arterial blood samples were collected before, during, and after intravenous [1-
14 C]AA infusion and were centrifuged (30 seconds, 18,000 g). Total lipids were extracted from the plasma (30 mL) with chloroform: methanol (3 mL, 2:1, v/v) and 0.1 mol/L KCl (1.5 mL) (Folch et al, 1957) . Previously, we showed that > 97% of plasma radioactivity, as determined in the organic phase (100 mL) by liquid scintillation counting, was due to [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]AA at the end of the 5-minute infusion (DeGeorge et al, 1989) .
Unlabeled, unesterified fatty acid concentrations were also determined in frozen arterial plasma (100 mL). Total lipids were extracted (Folch et al, 1957) and separated by thin-layer chromatography 60 silica gel plates, heptane: diethylether:glacial acetic acid (60:40:3, v/v/v). Unesterified fatty acids were scraped from the plate and converted to methyl ester derivatives (1% H 2 SO 4 in methanol, 3 hours, 701C), which were then analyzed by gas-liquid chromatography with flame ionization detection and quantified relative to an internal standard, heptadecanoic acid (17:0).
Quantitative Autoradiography
Serial cryostat-cut coronal brain sections of 20-mm thickness were placed with [ 14 C]methylmethacrylate standards (Amersham, Arlington Heights, IL, USA) on Ektascan C/RA film for 5 weeks. Radioactivity (nCi/g brain) in 81 bilateral anatomically identified regions (Paxinos and Watson, 1987) was determined by quantitative densitometry (NIH Image 1.62, Bethesda, MD, USA; http://rsb.info.nih.gov/nihimage/). Regional AA incorporation coefficients k* (mL/s per g brain) were calculated as (Robinson et al, 1992) :
(nCi/g wet brain weight) is brain radioactivity 20 minutes after beginning infusion, c * plasma (nCi/mL plasma) the arterial labeled unesterified AA, and t (min) the time after beginning [1-
14 C]AA infusion. Integrated plasma radioactivity (input function) was determined by trapezoidal integration and used to calculate k* for each experiment.
Regional incorporation rates of unesterified unlabeled AA from plasma into the brain, J in (nmol/s per g), were calculated as:
Phospholipase A 2 Activities
Rats were anesthetized with CO 2 and decapitated, and the brain was excised within 30 seconds, frozen in 2-methylbutane maintained at À401C with dry ice, and then stored at À801C. Half-brains were homogenized using a Tenbroeck tissue grinder on ice in 3 volumes of cold buffer (10 mmol/L HEPES (pH 7.5), 1 mmol/L EDTA, 0.34 mol/L sucrose, and protease inhibitor cocktail (Complete, Roche, Mannheim, Germany)). Homogenates were centrifuged (100,000 g, 1 hour, 41C). Supernatants corresponding to cytosolic fractions were assayed for cPLA 2 type IV and calcium independent (i)PLA 2 type VI activities (Yang et al, 1999) . The activity of sPLA 2 was measured using an sPLA 2 assay kit (Cayman, Ann Arbor, MI, USA), and protein was determined by the method described by Bradford (1976) .
Eicosanoid Concentrations
Rats were anesthetized with Nembutal (50 mg/kg, intraperitoneal) and subjected to high-energy head-focused microwave irradiation (5.5 kW, 4.4 seconds; Cober Electronics, Stamford, CT, USA) to denature brain enzymes and stop postmortem hydrolysis of fatty acids from stable lipid (Farias et al, 2008) . Tissue was weighed, homogenized with 18 volumes of hexane:isopropanol (3:2, v/v) using a glass homogenizer, and centrifuged (5 minutes, 800 g). Tissue residues were rinsed with hexane:isopropanol. The resultant lipid extract was concentrated to dryness under N 2 and resuspended in enzyme immunoassay buffer, and concentrations of PGE 2 , leukotriene (LT)B 4 , and TXB 2 were determined using assay kits (Oxford Biochemical, Oxford, MI, USA) (Basselin et al, 2007) .
Immunostaining
Free-floating coronal brain cryosections of 50-mm thickness were incubated for 30 minutes (801C/10 mmol/L citrate buffer: 0.05% Tween-20) and thereafter for 2 hours (2% goat or horse serum, 1% bovine serum albumin, 0.1% Triton X-100 in automation buffer (Biomeda, Foster City, CA, USA)). Sections were stained (18 hours/41C) with anticPLA 2 type IV (1:100), anti-sPLA 2 type IIA (1:200) or anti-COX-2 antibodies (1:150; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and were detected with Alexa Flour conjugates (1:250; 2 hours at room temperature; Invitrogen, Carlsbad, CA, USA). For colocalization, anti-Iba-1 was used to detect microglia. The nuclear stain, DAPI (4 0 ,6-diamidino-2-phenylindole) 2HCl, was used for counterstaining. Sections were matched for the cortical region and imaged by confocal microscopy.
Statistical Analyses
Data are reported as mean±s.d. An unpaired two-tailed t-test was used to compare means between HIV-1 Tg and control rats, with statistical significance set as Pr0.05.
Results
Physiology and Arterial Plasma Radioactivity
At surgery, HIV-1 Tg rats weighed 25% less than controls (334±13 g versus 416±17 g, n = 8, P < 0.0001). Their mean arterial blood pressure and heart rate were decreased significantly by 5% (132 ± 6 mm Hg versus 139±5 mm Hg) and 10% (360±42 b.p.m. versus 403 ± 36 b.p.m.), respectively, compared with control values. Rectal temperature was unchanged.
Mean integrated radioactivity in the plasma organic fraction, the input function for determining k* (equation 1), was 23% (P = 0.003) higher in HIV-1 Tg than in control rats (283,797±32,713 versus 231,088±26,997 (nCi Â s)/mL) (Figure 1 ).
Plasma Unlabeled Unesterified Fatty Acids
Of the 15 measured unlabeled unesterified plasma fatty acids, only the AA concentration differed significantly between groups, being 33% higher in HIV-1 Tg than in control rats (48±9 nmol/mL versus 36 ± 10 nmol/mL plasma, P = 0.024, n = 8).
Regional Brain Arachidonic Acid Incorporation Coefficients, k* Compared with controls, HIV-1 Tg rats showed elevated AA incorporation coefficients k* on coronal autoradiographs (Figure 2 ). Statistically significant increases in k* (equation 1) were found in 69 of the 81 brain regions examined, including the frontal cortex (43-57%), piriform cortex (79%), anterior Brain arachidonate in HIV-1 Tg ratscingulate cortex (41%), motor cortex (50-60%), somatosensory cortex (43-60%), globus pallidus (57%), olfactory tubercle (45%), amygdala (88%), hippocampus (73-86%), nucleus accumbens (53%), caudate putamen (55-58%), septum (54-67%), habenular nuclei (32-39%), dorsal lateral geniculate nucleus (31%), medial geniculate nucleus (34%), thalamus (35-55%), subthalamic nucleus (55%), hypothalamus (47-89%), interpeduncular nucleus (21%), substantia nigra (62%), superior colliculus (21-31%), inferior colliculus (38%), cerebellar white matter (107%), and choroid plexus (13%). The overall pattern of differences in HIV-1 Tg rat brains is illustrated in Figure 3 .
Regional Incorporation Rates
Regional AA incorporation rates J in were calculated by multiplying incorporation coefficients k* by the unlabeled unesterified AA concentration in each experiment (equation 2). As the mean plasma unesterified AA concentration was 33% higher in HIV-1 Tg than in control rats, J in was significantly higher than k* to this extent in the 69 brain regions. In controls, J in ranged from 63 Â 10 À4 nmol/s per g in the internal capsule (white matter) to 652 Â 10 À4 nmol/s per g in the choroid plexus. In HIV-1 Tg rats, J in ranged from 122 Â 10 À4 nmol/s per g in the periventricular area of the hypothalamus to 986 Â 10 À4 nmol/s per g in the choroid plexus.
Phospholipase Activities
Whole-brain activities of cPLA 2 -IV, sPLA 2 , and iPLA 2 -VI were increased significantly, by 47%, 67% and 49%, respectively, in HIV-1 Tg compared with control rats (Figure 4 ).
Eicosanoids
Brain PGE 2 and LTB 4 concentrations were increased significantly, by 4.0-and 4.5-fold, respectively, in HIV-1 Tg compared with control rats ( Figure 5 ). However, the mean TXB 2 concentration did not differ significantly between groups (P = 0.61).
Immunostaining
Immunostaining showed significantly increased neuronal immunofluorescence of cPLA 2 -IV, sPLA 2 -IIA, and COX-2 in the somatosensory cortex ( Figure 6 ). The fluorescence of cPLA 2 -IV was localized in the neuronal cytoplasm and extended within the processes ( Figures 6A and 6B) . The immunofluorescence of sPLA 2 -IIA was increased in the neuronal cytoplasm in HIV-1 Tg rats and dual staining with DAPI and Iba-1 indicated expression in neurons and process-bearing microglia ( Figures 6C and 6D ). Cyclooxygenase-2 staining was localized primarily to the neuronal cytoplasm with apparent minimal staining in the processes ( Figures 6E and 6F ).
Discussion
The brain of 7-to-9-month-old HIV-1 Tg rats compared with control rats showed statistically significant and widespread elevations in AA incorporation coefficients k*, of up to 107%, in 69 of 81 measured gray and white matter regions. These elevations corresponded to significantly higher incorporation rates J in , the product of k* and the plasma unesterified AA concentration, which was elevated by 33%. Of 15 unesterified fatty acids assayed in the plasma, only the AA concentration was elevated significantly, and integrated plasma radioactivity due to [1-14 C]AA during and after tracer infusion was significantly greater in HIV-1 Tg rats.
Whole-brain activities of cPLA 2 -IV (which selectively hydrolyzes AA from the sn-2 position of phospholipid (Six and Dennis, 2000) ), iPLA 2 -VI (selective for DHA hydrolysis (Strokin et al, 2004) ), and sPLA 2 (which can hydrolyze both AA and DHA (Six and Dennis, 2000) ), were elevated significantly in HIV-1 Tg rats, as were brain concentrations of the AA metabolites, PGE 2 and LTB 4 , whereas TXB 2 concentration was not changed significantly. The globally elevated cPLA 2 -IV and sPLA 2 activities corresponded at the local level in the cortex to increased immunostaining for these enzymes, as well as for COX-2. COX-2 can be coupled functionally and is often colocalized with cPLA 2 , and catalyzes formation from AA of PGE 2 and other eicosanoids (Kaufmann et al, 1997; Ong et al, 1999) . Taken (n = 6). **P < 0.01, ***P < 0.001 compared with control (unpaired t-test). cPLA 2 , cytosolic phospholipase; HIV, human immunodeficiency virus; iPLA 2 , calcium independent phospholipase; sPLA 2 , secretory phospholipase; Tg, transgenic. together, the data provide strong evidence for an upregulated brain AA cascade in HIV-1 Tg rats (Bosetti, 2007; Lee et al, 2008; Rao et al, 2007; Rosenberger et al, 2004) , but also suggest disturbed DHA metabolism.
The observed changes could reflect microglial activation with release of proinflammatory cytokines, because cytokine receptors may be coupled to cPLA 2 and sPLA 2 activation and to downstream AA metabolism by COX or lipoxygenase enzymes (Hoeck et al, 1993; Moolwaney and Igwe, 2005; Murakami et al, 1999) , as well as to excitotoxicity involving glutamatergic N-methyl-D-aspartate receptors Rao et al, 2007) . Indeed, the brain of the Figure 6 Representative confocal images of (A, B; monochrome) cPLA 2 , (C, D; red) sPLA 2 , and (E, F; red) COX-2 immunofluorescence in the somatosensory cortex (layers 3-5) of (panels A, C, E) control and (panels B, D, F) HIV-1 Tg rats. Immunoreactivity was primarily localized to the neuronal cytoplasm and processes. Scale bar = 50 mm. Dual immunostaining (insets) indicate that sPLA 2 (red) was expressed in both neurons (blue) and Iba-1 + microglia (green; colocalized-yellow) and COX-2 (red) in neurons. Inset scale bar = 20 mm. cPLA 2 , cytosolic phospholipase; COX-2, cyclooxygenase-2; HIV, human immunodeficiency virus; iPLA 2 , calcium independent phospholipase; sPLA 2 , secretory phospholipase; Tg, transgenic.
7-to-9-month-old HIV-1 Tg rat shows elevated protein and mRNA levels of tumor necrosis factora, interleukin-1b, CD11B (a marker of microglial activation), cPLA 2 -IV, sPLA 2 -IIA, COX-2, and membrane PGE 2 synthase (Rao JS and Rapoport SI, unpublished data). Supporting such changes, intracerebroventricular injection in rodents of envelope gp120 or the Tat protein of the HIV-1 virus increased COX-2 and PGE 2 synthase, PGE 2 concentration and cytokines, and activated N-methyl-D-aspartate receptors (Bagetta et al, 1998; D'Aversa et al, 2005; Flora et al, 2006) . Neuroinflammation and upregulated brain AA metabolism also occur in HAD patients (see the 'Introduction' section) (D'Aversa et al, 2005; Griffin et al, 1994; Wesselingh et al, 1994) .
iPLA 2 -VI, the activity of which was increased in the HIV-1 Tg rat, is considered Ca 2 + independent and DHA selective on the basis of in vitro studies (Six and Dennis, 2000; Strokin et al, 2004) , but may be activated when Ca 2 + is released from the endoplasmic reticulum to dissociate inhibitory calmodulin from the enzyme (Rosa and Rapoport, 2009 ). Human immunodeficiency virus Tat can activate ryanodine receptors on the endoplasmic reticulum to promote such a release (Norman et al, 2008) , as can a combination of elevated AA and LTB 4 (Striggow and Ehrlich, 1997) , which may explain the increased iPLA 2 -VI activity in the HIV-1 Tg brain. iPLA 2 can also be activated by gp120 by the p38 mitogen-activated protein kinase (Kan et al, 2006) .
The selective elevation of the unesterified plasma AA concentration, and the increased integrated plasma [1-
14 C]AA concentration during intravenous [1-
14 C]AA infusion in HIV-1 Tg rats, indicate a prolonged half-life of unesterified plasma AA (Rapoport et al, 1982) . Prolongation may follow cytokine release from infected monocytes or activation of the AA cascade in peripheral organs and white cells (Killebrew et al, 2005) .
Both k* and J in for AA in control rats in this study were lower than reported in other studies (Basselin et al, 2007) , but this may reflect dietary differences. The unesterified AA concentration in the 2018 diet of this study was 0.05 mmol/g compared with 4 mmol/g in the NIH-31 diet used in other studies. The 2018 DHA concentration also was lower, 0.10 mmol/g compared with 2.9 mmol/g in the NIH-31 diet.
In summary, multiple markers of brain AA metabolism are upregulated in 7-to-9-month old HIV-1 Tg compared with control rats: regional AA incorporation coefficients and rates, cPLA 2 -IV and sPLA 2 activities and immunostaining, COX-2 immunostaining, and PGE 2 and LTB 4 concentrations. These changes correspond to the evidence for neuroinflammation in the rats. The data further support the HIV-1 Tg rat as a relevant model for human HIV-1 infection and suggest that brain values of k* and J in for AA would be elevated in relation to neuroinflammation in HAD and possibly non-demented patients. This prediction could be tested with intravenous [1-11 C]AA and positron emission tomography, which have been used to show elevated AA incorporation in patients with Alzheimer's disease in relation to neuroinflammation (Esposito et al, 2008) . In HIV-1 patients, positron emission tomography neuroimaging might help to relate altered brain AA metabolism to peripheral viral load, CD4 + T cell count (Brust et al, 2006) , dementia severity, and behavioral deficits (Anthony and Bell, 2008) , or to evaluate effects of retroviral therapies with different abilities to enter the brain (May et al, 2007) , or of nonsteroidal antiinflammatory and other drugs (Flora et al, 2006) .
